收藏切换
The effect of trastuzumab combined with TP regimen on PAI-1,HER2 receptors and lymphocyte subsets in breast cancer patients
收藏切换
Xun FANG1, Beibei LIU1, Qilong ZHU1, Hao JIAO2, *
World Clinical Drug | 2025, 46(7) : 675 - 680
Less
收藏切换
World Clinical Drug | 2025, 46(7): 675-680
• Article •
The effect of trastuzumab combined with TP regimen on PAI-1,HER2 receptors and lymphocyte subsets in breast cancer patients
Full
Xun FANG1, Beibei LIU1, Qilong ZHU1, Hao JIAO2, *
Affiliations
  • 1.Department of Pharmacy, Yingshang County People's Hospital, Yingshang 236200, Anhui Province, China
  • 2.Department of Pharmacy, the First Affiliated Hospital of Wannan Medical College/Yijishan Hospital, Wuhu 241001, Anhui Province, China
Published: 2025-07-10 doi: 10.13683/j.wph.2025.07.008
Outline
收藏切换
Objective

To explore the effect of trastuzumab combined with TP regimen in the treatment of breast cancer,and to analyze its effect on plasminogen activator inhibitor(PAI)-1, human epidermal growth factor receptor(HER)2 receptor and lymphocyte subsets.

Methods

A total of 100 breast cancer patients in Yingshang County People's Hospital from January 2020 to November 2024 were selected for the study and randomly divided into the observation group and the control group, with 50 cases in each group. Five cases dropped out during the study. Eventually, the patients were divided into an observation group of 48 cases and a control group of 47 cases. The control group was treated with the TP regimen,while the observation group was treated with trastuzumab combined with TP regimen. The clinical efficacy, PAI-1, HER2,lymphocyte subsets, tumor markers and the occurrence of adverse reactions of the two groups were compared.

Results

After treatment, the total effective rate of the observation group was higher than that of the control group(79.17% vs. 53.19%, P<0.05). The level of PAI-1 and the expression of HER2 receptor in the observation group were lower than those in the control group(P<0.05). The levels of cluster of differentiation(CD)3+ and CD4+ in the observation group were higher than those in the control group(P<0.05), while CD8+ was lower than that in the control group(P<0.05). The levels of carbohydrate antigen 153, tissue polypeptide specific antigen and carcinoembryonic antigen in the observation group were lower than those in the control group(P<0.05). There was no statistically significant difference in adverse reactions between the two groups(P>0.05).

Conclusion

Trastuzumab combined with TP regimen has a significant therapeutic effect in the treatment of breast cancer. It can effectively inhibit tumor progression and also improve the levels of PAI-1, HER2 and the distribution of peripheral blood lymphocyte subsets.

trastuzumab  /  breast cancer  /  human epidermal growth factor receptor 2  /  lymphocyte subset
方栒, 刘贝贝, 朱其龙, 焦浩. 曲妥珠单抗联合TP方案对乳腺癌患者PAI-1、HER2受体及淋巴细胞亚群影响. 世界临床药物, 2025 , 46 (7) : 675 -680 . DOI: 10.13683/j.wph.2025.07.008
Xun FANG, Beibei LIU, Qilong ZHU, Hao JIAO. The effect of trastuzumab combined with TP regimen on PAI-1,HER2 receptors and lymphocyte subsets in breast cancer patients[J]. World Clinical Drug, 2025 , 46 (7) : 675 -680 . DOI: 10.13683/j.wph.2025.07.008
Year 2025 volume 46 Issue 7
50
14
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.07.008
  • Receive Date:2025-03-02
  • Online Date:2026-11-09
  • Published:2025-07-10
Article Data
Affiliations
History
  • Received:2025-03-02
Affiliations
    1.Department of Pharmacy, Yingshang County People's Hospital, Yingshang 236200, Anhui Province, China
    2.Department of Pharmacy, the First Affiliated Hospital of Wannan Medical College/Yijishan Hospital, Wuhu 241001, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.07.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT